Rho Ventures Iv Holdings Llc - Net Worth and Insider Trading

Rho Ventures Iv Holdings Llc Net Worth

The estimated net worth of Rho Ventures Iv Holdings Llc is at least $15 Million dollars as of 2024-11-13. Rho Ventures Iv Holdings Llc is the 10% Owner of Anacor Pharmaceuticals Inc and owns about 1,533,600 shares of Anacor Pharmaceuticals Inc (ANAC) stock worth over $15 Million. Details can be seen in Rho Ventures Iv Holdings Llc's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Rho Ventures Iv Holdings Llc has not made any transactions after 2011-12-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Rho Ventures Iv Holdings Llc

Rho Ventures Iv Holdings Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Rho Ventures Iv Holdings Llc owns 3 companies in total, including IntraLinks Holdings Inc (IL) , Rocket Pharmaceuticals Inc (RCKT) , and Anacor Pharmaceuticals Inc (ANAC) .

Click here to see the complete history of Rho Ventures Iv Holdings Llc’s form 4 insider trades.

Insider Ownership Summary of Rho Ventures Iv Holdings Llc

Ticker	Comapny	Transaction Date	Type of Owner
IL	IntraLinks Holdings Inc	2017-01-19	10 percent owner
RCKT	Rocket Pharmaceuticals Inc	2015-11-16	10 percent owner
ANAC	Anacor Pharmaceuticals Inc	2014-02-03	10 percent owner

Rho Ventures Iv Holdings Llc Latest Holdings Summary

Rho Ventures Iv Holdings Llc currently owns a total of 1 stock. Rho Ventures Iv Holdings Llc owns 1,533,600 shares of Anacor Pharmaceuticals Inc (ANAC) as of December 20, 2011, with a value of $15 Million.

Latest Holdings of Rho Ventures Iv Holdings Llc

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
ANAC	Anacor Pharmaceuticals Inc	2011-12-20	1,533,600	9.82	15,059,952

Holding Weightings of Rho Ventures Iv Holdings Llc

Rho Ventures Iv Holdings Llc Form 4 Trading Tracker

According to the SEC Form 4 filings, Rho Ventures Iv Holdings Llc has made a total of 0 transactions in Anacor Pharmaceuticals Inc (ANAC) over the past 5 years. The most-recent trade in Anacor Pharmaceuticals Inc is the sale of 0 shares on December 20, 2011, which brought Rho Ventures Iv Holdings Llc around $0.

Insider Trading History of Rho Ventures Iv Holdings Llc

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Rho Ventures Iv Holdings Llc Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Rho Ventures Iv Holdings Llc Ownership Network

Ownership Network List of Rho Ventures Iv Holdings Llc

No Data

Ownership Network Relation of Rho Ventures Iv Holdings Llc

Rho Ventures Iv Holdings Llc Owned Company Details

What does IntraLinks Holdings Inc do?

Who are the key executives at IntraLinks Holdings Inc?

Rho Ventures Iv Holdings Llc is the 10 percent owner of IntraLinks Holdings Inc. Other key executives at IntraLinks Holdings Inc include 10 percent owner Ta Associates, L.p. , 10 percent owner Ta Atlantic & Pacific V L P , and 10 percent owner Ta Investors Ii L.p. .

IntraLinks Holdings Inc (IL) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of IntraLinks Holdings Inc (IL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of IntraLinks Holdings Inc (IL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

IntraLinks Holdings Inc (IL)'s detailed insider trading history can be found in Insider Trading Tracker table.

IntraLinks Holdings Inc Insider Transactions

No Available Data

What does Rocket Pharmaceuticals Inc do?

Who are the key executives at Rocket Pharmaceuticals Inc?

Rho Ventures Iv Holdings Llc is the 10 percent owner of Rocket Pharmaceuticals Inc. Other key executives at Rocket Pharmaceuticals Inc include Chief Medical Officer Mark Andrew White , See Remarks John Militello , and General Counsel Martin Wilson .

Rocket Pharmaceuticals Inc (RCKT) Insider Trades Summary

Over the past 18 months, Rho Ventures Iv Holdings Llc made no insider transaction in Rocket Pharmaceuticals Inc (RCKT). Other recent insider transactions involving Rocket Pharmaceuticals Inc (RCKT) include a net sale of 22,492 shares made by John Militello , a net sale of 48,601 shares made by Gaurav Shah , and a net sale of 582,989 shares made by Gotham Makker .

In summary, during the past 3 months, insiders sold 19,727 shares of Rocket Pharmaceuticals Inc (RCKT) in total and bought 0 shares, with a net sale of 19,727 shares. During the past 18 months, 779,172 shares of Rocket Pharmaceuticals Inc (RCKT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 779,172 shares.

Rocket Pharmaceuticals Inc (RCKT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Rocket Pharmaceuticals Inc Insider Transactions

No Available Data

What does Anacor Pharmaceuticals Inc do?

Who are the key executives at Anacor Pharmaceuticals Inc?

Rho Ventures Iv Holdings Llc is the 10 percent owner of Anacor Pharmaceuticals Inc. Other key executives at Anacor Pharmaceuticals Inc include Executive VP and CFO Graeme Bell , EVP and General Counsel Ryan T Sullivan , and director & President and CEO Paul L Berns .

Anacor Pharmaceuticals Inc (ANAC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Anacor Pharmaceuticals Inc (ANAC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Anacor Pharmaceuticals Inc (ANAC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Anacor Pharmaceuticals Inc (ANAC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Anacor Pharmaceuticals Inc Insider Transactions

No Available Data

Rho Ventures Iv Holdings Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Rho Ventures Iv Holdings Llc. You might contact Rho Ventures Iv Holdings Llc via mailing address: 152 W. 57th Street, 23rd Floor, New York Ny 10019.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.